Bristol-Myers Squibb (BMS) has agreed to sell its small-molecule active pharmaceutical ingredient (API) manufacturing facility in Swords, Ireland, to Seoul, South Korea-based contract development and ...
SK Biotek plans to operate the Swords, Ireland API manufacturing facility as a contract development and manufacturing site. SK Biotek Co., Ltd, a wholly-owned subsidiary of SK Holdings, will be the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results